zilucoplan
AZ’s Alexion plans hit a snag as Ultomiris flunks ALS trial
Phil Taylor
Alexion, amyotrophic lateral sclerosis, AstraZeneca, complement therapeutics, neurodegenerative disease, Soliris, UCB, Ultomiris, zilucoplan
0 Comment
X
AZ’s Alexion plans hit a snag as Ultomiris flunks ALS trial
https://pharmaphorum.com/news/azs-alexion-takeover-hits-a-snag-as-ultomiris-flunks-als-trial/